ACTIV Update: Making Major Strides in COVID-19 Therapeutic Development
NIH Director's Blog: Drug Development
FEBRUARY 16, 2021
ACTIV was founded last April to accelerate drug research that typically requires more than a decade of clinical ups and downs to develop a safe, effective therapy. Therapeutics Clinical Working Group : Prioritizes therapeutic agents for testing within an adaptive master protocol strategy for clinical research.
52 
Let's personalize your content